A. Bernardi
University of Bologna
11 Papers
94 Citations
A. Bernardi is an academic researcher from University of Bologna. The author has contributed to research in topics: Breast cancer & Standardized uptake value. The author has an hindex of 5, co-authored 11 publications.
Chat about Author
Papers
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy.
Andrea Martoni,Claudio Zamagni,Sara Quercia,M. Rosati,Nicoletta Cacciari,A. Bernardi,Alessandra Musto,Stefano Fanti,Donatella Santini,Mario Taffurelli +9 more
TL;DR: A pathologic complete response (pCR) and minimal residual disease (pMRD) after preoperative chemotherapy for early stage or locally advanced breast cancer correlates with a good prognosis.
66
•Journal Article
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
Andrea Martoni,Stefano Fanti,Claudio Zamagni,M. Rosati,P. De Iaco,A. D’Errico Grigioni,Paolo Castellucci,Sara Quercia,Alessandra Musto,L. Ricci Maccarini,Egesta Lopci,A. Bernardi +11 more
TL;DR: Patients with AOC who present normalization of SUVmax after 3 courses of na-CT have a high likelihood of benefiting from 3 additional courses in order to obtain pCR or pMDR and receiving optimal surgery.
36
Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies
Claudio Zamagni,Ralph M. Wirtz,Pierandrea De Iaco,M. Rosati,Elke Veltrup,F. Rosati,Elisa Capizzi,Nicoletta Cacciari,C. Alboni,A. Bernardi,Francesco Massari,Sara Quercia,Antonietta D'Errico Grigioni,Manfred Dietel,Jalid Sehouli,Carsten Denkert,Andrea Martoni +16 more
TL;DR: It is concluded that pretreatment ESR1 mRNA is associated with tumour growth and is a strong prognostic factor in ovarian cancer, independent of the strongest clinical parameters used in clinical routine.
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.
Igor Diemberger,Giulia Massaro,Marta Cubelli,Daniela Rubino,Sara Quercia,Cristian Martignani,Matteo Ziacchi,Mauro Biffi,A. Bernardi,Nicoletta Cacciari,Claudio Zamagni,Giuseppe Boriani +11 more
TL;DR: The results confirm the high prevalence of QTc prolongation after chemotherapy and suggest that BC-QTc may help in stratifying arrhythmic risk in real-world clinical practice.
10
•Journal Article
Trastuzumab plus estrogen suppression as salvage treatment in a case of liver failure due to metastatic breast cancer.
TL;DR: Tastuzumab plus estrogen suppression can be an effective salvage therapy in patients with liver failure due to metastatic HER2 and ER/PgR-positive breast cancer.
9